EVERSANA provides integrated commercial services for the life sciences sector, addressing drug pricing, promotion, access, reimbursement, adherence, and product delivery challenges.

EVERSANA

ProGamma Science Corporation is a multidisciplinary company that provides comprehensive and economic solutions for technical operations and compliance in the pharmaceutical, biopharmaceutical, Natural Health Products, and medical devices industries. Self-described as offering high quality for client projects.

PROGAMMA SCIENCE

NGT BioPharma Consultants is a drug development and advanced technologies consultancy firm that supports small molecules and biologics across the drug development continuum from late discovery through preclinical and clinical development, registration, commercialization, and life cycle management.

NGT BioPharma Consultants

Frontiers Health is a global health innovation event focused on digital therapies, breakthrough technologies, healthcare transformation, investments, and ecosystem development. It offers networking and insights to companies, entrepreneurs, and venture capitalists.

Metric
Company Name	EVERSANA	PROGAMMA SCIENCE	NGT BioPharma Consultants	Frontiers Health
Symbol
MSH ID	COM:EVERSANA	CA:PROGAMMA	COM:NGTBIOPHARMACONSULTANTS	HEALTH:FRONTIERS
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Commercial & Professional Services	Healthcare & Health Services
Industry	Pharmaceuticals	Pharmaceuticals & Biopharmaceuticals	Pharmaceuticals	Healthcare
Country	US	CA	US	DE
Stage
Employee Count
Website	eversana.com	progamma.ca	ngtbiopharmaconsultants.com	frontiers.health
LinkedIn		progamma
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic				6.22K
Web Traffic Growth				-0.32
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:EVERSANA

EVERSANA

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue